Company Overview

Adaptive Biotechnologies translates scale and precision of the adaptive immune system into products to diagnose and treat disease.
Headquarters: Seattle, Washington, United States, North America
Categories: Biotechnology, Health Care, Therapeutics
Founded Date: 2009
Founders: Chad Robins, Christopher Carlson, Harlan Robins
Funding Status: IPO
Number of Employees: 501-1000

Last Funding Round

Announced Date: Sep 12, 2022
Funding Type: Post-IPO Debt
Money Raised: $125,000,000
Total Investors: 1
Lead Investors: OrbiMed
View Adaptive Biotechnologies on Crunchbase